Skip to content

Lifebalance; an important outcome for fatigue management in neuromuscular diseases

Lifebalance; an important outcome for fatigue management in neuromuscular diseases - LiBaS: LifeBalance Study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48997
Enrollment
60
Registered
2019-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facioscapulohumeral dystrophy (FSHD) and Mitochondrial myopathy (MM)

Interventions

The individualized one-to-one face-to-face program, MF, consists of education, practice, evaluation and implementation of energy conservation strategies in daily life. Following education, persons a

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age 18 years or older; - diagnose: FacioScapuloHumerale Dystrofie (FSHD) or Mitochondrial Myopathy (MM); - sufficient command of Dutch language, to be able to fill in questionnaires; - Checklist Individual Strength- fatigue (CIS-Fatigue) * 35, indicating severe fatigue

Exclusion criteria

Exclusion criteria: - depression or other major psychiatric disorders - severe cardiorespiratory and/or onclological disease limiting life expectance or independency in daily life

Design outcomes

Primary

MeasureTime frame
The primary outcome will be participation in activities measured with the Canadian Occupational Performance Measure, COPM (performance and satisfaction scales).

Secondary

MeasureTime frame
Secondary outcomes will be activity balance and life balance (Activity Calculator, AC, Activity Card Sort-Dutch version, ACS-NL(18-65)) and life balance (Occupational Balance Questionnaire, Dutch version, OBQ-NL); fatigue (Checklist Individual Strength-subscale fatigue, CIS-fatigue); participation (Utrecht Scale for Evaluation of Rehabilitation-Participation, USER-P); health status (General Health Questionnaire, GHQ); quality of life (Short Form-36, SF-36); and self-efficacy regarding implementation of energy conservation strategies (Self-Efficacy in Performance of Energy Conservation Strategies Assessment, SEPECSA).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)